Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
TECX · NASDAQ · Biological Products, (No Diagnostic Substances)
$20.73−0.31 (−1.47%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Tectonic Therapeutic (TECX) · oqro.io/stocks/TECX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Oct 29, 2026
Aberdeen Group plc cut its TECX stake below 5% (2.5%)SourceInsider trade · Traded Sep 30, 2026 · Filed Oct 2, 2026
Officer sold ~$12K of TECX shares in the open marketSourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Deep Track Capital, LP no longer reported TECX for Q3 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Deep Track Capital, LP disclosed a new position in TECX for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Paradigm Biocapital Advisors LP no longer reported TECX for Q1 2025SourceInsider trade · Traded Apr 11, 2025 · Filed Apr 11, 2025
Director purchased ~$876K of TECX shares in the open marketSourceInsider trade · Traded Apr 10, 2025 · Filed Apr 11, 2025
Director purchased ~$767K of TECX shares in the open marketSourceInsider trade · Traded Apr 9, 2025 · Filed Apr 11, 2025
Director purchased ~$237K of TECX shares in the open marketSourceInsider trade · Traded Apr 11, 2025 · Filed Apr 11, 2025
Director purchased ~$155K of TECX shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Paradigm Biocapital Advisors LP disclosed a new position in TECX for Q4 2024SourceInsider trade · Traded Feb 5, 2025 · Filed Feb 7, 2025
Director purchased ~$33M of TECX shares in the open marketSourceInsider trade · Traded Feb 5, 2025 · Filed Feb 7, 2025
Director purchased ~$7M of TECX shares in the open marketSourceInsider trade · Traded Feb 5, 2025 · Filed Feb 7, 2025
CFO purchased ~$250K of TECX shares in the open marketSourceInsider trade · Traded Oct 22, 2024 · Filed Oct 24, 2024
Director purchased ~$10.1M of TECX shares in the open marketSourceInsider trade · Traded Apr 10, 2025 · Filed Apr 11, 2025
Director purchased ~$135K of TECX shares in the open marketSourceInsider trade · Traded Apr 9, 2025 · Filed Apr 11, 2025
Director purchased ~$74K of TECX shares in the open marketSourceInsider trade · Traded Apr 9, 2025 · Filed Apr 11, 2025
Director purchased ~$42K of TECX shares in the open marketSourceInsider trade · Traded Apr 9, 2025 · Filed Apr 11, 2025
Director purchased ~$13K of TECX shares in the open marketSourceInsider trade · Traded Apr 7, 2025 · Filed Apr 9, 2025
Director purchased ~$7.05M of TECX shares in the open marketSourceInsider trade · Traded Apr 7, 2025 · Filed Apr 9, 2025
Director purchased ~$1.5M of TECX shares in the open marketSourceInsider trade · Traded Apr 7, 2025 · Filed Apr 7, 2025
Director sold ~$8.55M of TECX shares in the open marketSource